tiprankstipranks
Revez Corporation Ltd. (SG:RCU)
SGX:RCU
Want to see SG:RCU full AI Analyst Report?

Revez Corporation Ltd. (RCU) AI Stock Analysis

1 Followers

Top Page

SG:RCU

Revez Corporation Ltd.

(SGX:RCU)

Select Model
Select Model
Select Model
Neutral 46 (OpenAI - Gpt-5.6Sol)
Rating:46Neutral
Price Target:
S$0.07
▲(72.50% Upside)
Action:Reiterated
Date:08/18/26
The score is held down primarily by weak financial performance (structurally negative gross profit, persistent losses, and ongoing cash burn), partially offset by a cleaner balance sheet. Technicals are supportive with price above major moving averages and positive MACD, but extremely high RSI indicates stretched momentum. Valuation remains unattractive due to negative earnings and no dividend yield support.
Positive Factors
Revenue Rebound
The sharp 2025 revenue recovery indicates renewed business activity and customer demand after a weak base. Sustaining this growth could improve operating leverage and support scale, although profitability must still follow for the rebound to become durable.
Negative Factors
Persistently Negative Gross Profit
Recurring negative gross profit indicates the core delivery model has not covered direct costs over an extended period. This points to unresolved pricing, project execution, or cost-structure issues and limits the durability of revenue growth without fundamental margin repair.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Rebound
The sharp 2025 revenue recovery indicates renewed business activity and customer demand after a weak base. Sustaining this growth could improve operating leverage and support scale, although profitability must still follow for the rebound to become durable.
Read all positive factors

Revez Corporation Ltd. (RCU) vs. iShares MSCI Singapore ETF (EWS)

Revez Corporation Ltd. Business Overview & Revenue Model

Company Description
Assurance Healthcare Limited, an investment holding company, operates in the healthcare business in Singapore. The company develops and distributes healthcare products and services and manages healthcare solutions through retail, direct selling, n...
How the Company Makes Money
RCU makes money through revenue generated by its operating business segments, which have included technology-related solutions/services and real estate-related activities (such as development, investment, or project-based income depending on the s...

Revez Corporation Ltd. Financial Statement Overview

Summary
Despite strong revenue rebound in 2025 (+72% vs. 2024) and improved leverage, fundamentals remain weak: gross profit is negative across 2020–2025, losses persist (though narrowed in 2025), and operating/free cash flow are negative for 2021–2025, indicating ongoing cash burn and unproven unit economics.
Income Statement
22
Negative
Balance Sheet
67
Positive
Cash Flow
26
Negative
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue929.00K740.00K588.00K304.00K0.007.53M
Gross Profit-356.00K-92.00K-66.58K-96.50K-7.38K-30.59K
EBITDA-489.00K-644.00K-1.18M-1.41M656.18K-1.23M
Net Income-635.00K-732.00K-1.14M-3.03M-4.37M-1.93M
Balance Sheet
Total Assets7.04M7.25M7.75M9.59M6.31M11.54M
Cash, Cash Equivalents and Short-Term Investments868.00K1.24M2.16M3.81M1.81M3.32M
Total Debt53.00K116.00K180.33K318.43K1.71M3.14M
Total Liabilities1.24M1.09M793.94K1.29M5.00M5.46M
Stockholders Equity5.93M6.28M7.01M8.15M1.32M5.69M
Cash Flow
Free Cash Flow-453.00K-779.00K-1.50M-1.64M-1.27M-2.91M
Operating Cash Flow-214.00K-538.00K-1.05M-1.63M-656.33K-459.97K
Investing Cash Flow-358.00K-241.00K-444.73K-5.55M630.43K-613.00K
Financing Cash Flow-70.00K-149.00K-149.00K9.19M-1.48M1.55M

Revez Corporation Ltd. Technical Analysis

Technical Analysis Sentiment
Positive
Last Price0.04
Price Trends
50DMA
0.06
Positive
100DMA
0.05
Positive
200DMA
0.05
Positive
Market Momentum
MACD
<0.01
Negative
RSI
75.52
Negative
STOCH
87.18
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SG:RCU, the sentiment is Positive. The current price of 0.04 is below the 20-day moving average (MA) of 0.07, below the 50-day MA of 0.06, and below the 200-day MA of 0.05, indicating a bullish trend. The MACD of <0.01 indicates Negative momentum. The RSI at 75.52 is Negative, neither overbought nor oversold. The STOCH value of 87.18 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SG:RCU.

Revez Corporation Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
71
Outperform
S$729.31M111.6634.36%53.91%157.14%
61
Neutral
$37.18B12.37-10.20%1.83%8.50%-7.62%
56
Neutral
S$21.19M5.878.22%12.18%
46
Neutral
S$21.07M-32.00-10.40%63.16%42.86%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
SG:RCU
Revez Corporation Ltd.
0.08
0.03
48.15%
SG:QS9
Global Invacom
0.05
0.02
52.94%
SG:WJ9
Advanced Systems Automation Limited
SG:A31
Addvalue Technologies Ltd
0.20
0.17
607.14%
SG:BDR
Willas-Array Electronics (Holdings) Limited
1.11
0.03
2.78%
SG:M11
Manufacturing Integration Technology Ltd.
0.05
0.03
150.00%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 18, 2026